RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fj.clnu.2017.12.004
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.clnu.2017.12.004
| Subject | Predicate | Object |
|---|---|---|
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prism:doi |
10.1016/j.clnu.2017.12.004 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
prism:doi |
10.1016/j.clnu.2017.12.004 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prism:publicationDate |
2019-02-05 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
prism:publicationDate |
2019-02-05 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
dcterms:title |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
dcterms:title |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
owl:sameAs |
https://semopenalex.org/work/W2774713064 |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
owl:sameAs |
https://semopenalex.org/work/W2774713064 |
ripekg:work/10.1111%2Fadb.12650Expression of Concern: The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1111%2Fadb.12650Expression of Concern: The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1111%2Fpai.12978EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1111%2Fpai.12978EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.clnu.2017.12.004Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |